Ena Respiratory Funding: $33M Raised, Series B (2025)
Ena Respiratory is based in Melbourne, Victoria, Australia. It has raised $33M in total funding. Latest round: Series B.
Ena Respiratory funding overview
Ena Respiratory is based in Melbourne, Victoria, Australia. Ena Respiratory has raised $33M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2025. The round record for Ena Respiratory runs through 2025; nothing later has been disclosed. Investors on record include Brandon Capital, The Minderoo Foundation, Uniseed, Flu Lab, Gates Foundation, Stoic Venture Capital. 6 distinct backers are named across the disclosed rounds.
Ena Respiratory at a glance
Total raised
$33M
Latest round
Series B
Latest round date
October 2025
Headquarters
Melbourne, Victoria, Australia
Notable investors
Brandon Capital, The Minderoo Foundation, Uniseed, Flu Lab, Gates Foundation, Stoic Venture Capital
Frequently asked about Ena Respiratory funding
How much has Ena Respiratory raised?
Ena Respiratory has raised $33M in total disclosed funding across the rounds on record.
Who has invested in Ena Respiratory?
Brandon Capital, The Minderoo Foundation, Uniseed, Flu Lab, Gates Foundation, Stoic Venture Capital are named among the investors backing Ena Respiratory.
What was the latest Ena Respiratory funding round?
The most recent disclosed round is a Series B, announced in October 2025.
Where is Ena Respiratory based?
Ena Respiratory is based in Melbourne, Victoria, Australia.
When did Ena Respiratory last raise?
The last disclosed Ena Respiratory round closed in October 2025 at Series B.
We update the Ena Respiratory record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Melbourne and their backers are listed below.
